A. Habib

发表

Clinical outcomes of microendoscopic foraminotomy and decompression in the cervical spine.

Ricky H. Wong, S. Lam, R. Fessler, 2014, World neurosurgery.

Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman

J. Safdieh, D. Gilden, D. Schmid, 2009, Journal of Neurovirology.

Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.

A. Benson, M. Mulcahy, R. Salem, 2014, International journal of radiation oncology, biology, physics.

Update on immune‐mediated therapies for myasthenia gravis

T. Mozaffar, A. Habib, Ghazaleh Ahmadi Jazi, 2020, Muscle & nerve.

Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study

R. Finkel, J. Statland, A. Connolly, 2021, Neurotherapeutics.

Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds

H. Boushey, Joseph Kang, P. Avila, 2013, Journal of Allergy and Clinical Immunology.

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

M. Benatar, M. Bromberg, M. Pasnoor, 2020, JAMA neurology.

Pretransplant Portal Vein Recanalization—Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis

M. Abecassis, D. Ganger, T. Baker, 2015, Transplantation.

Emerging drugs for amyotrophic lateral sclerosis

H. Mitsumoto, A. Habib, 2011, Expert opinion on emerging drugs.

Locoregional therapy of hepatocellular carcinoma.

R. Salem, B. Thornburg, R. Hickey, 2015, Clinics in liver disease.

Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy

A. Benson, M. Mulcahy, R. Salem, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Transarterial approaches to primary and secondary hepatic malignancies

R. Salem, B. Thornburg, R. Hickey, 2015, Nature Reviews Clinical Oncology.

Kidney, Adrenal Gland, and Paraganglia

Xiaoqi Lin, A. Riaz, A. Habib, 2019, Atlas of Cytopathology and Radiology.

Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.

D. Ganger, E. Wang, M. Mulcahy, 2014, Journal of Vascular and Interventional Radiology.

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience

A. Benson, M. Abecassis, D. Ganger, 2018, Hepatology.

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

A. Pestronk, S. Subramony, J. Statland, 2022, Neurology.

Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy

M. Abecassis, D. Ganger, M. Mulcahy, 2014, Hepatology.

The neuropathology of leprosy.

T. Mozaffar, A. Habib, 2002, Archives of neurology.

Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.

D. Ganger, T. Baker, R. Salem, 2017, European journal of radiology.

Defensive medicine in neurosurgery: does state-level liability risk matter?

Joshua M Rosenow, Brian V Nahed, H Hunt Batjer, 2015, Neurosurgery.

Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma.

M. Abecassis, D. Ganger, M. Lacouture, 2014, Journal of hepatology.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Attitudes Toward Noninterventional Observational Studies in US and Australian Patients With Sporadic Inclusion Body Myositis.

M. Needham, V. Mathew, T. Mozaffar, 2020, Journal of Clinical Neuromuscular Disease.

Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis.

R. Vogelzang, R. Salem, B. Thornburg, 2015, Journal of vascular and interventional radiology : JVIR.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

M. Benatar, M. Tosun, M. Kurtoğlu, 2023, The Lancet Neurology.

Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Perspective on Current Evidence and Clinical Knowledge

R. Fessler, Z. Smith, C. Lawton, 2012, Minimally invasive surgery.

Locoregional therapy of hepatocellular carcinoma.

R. Salem, B. Thornburg, R. Hickey, 2015, Clinics in liver disease.

Therapeutic Strategies for Diabetic Neuropathy

T. Brannagan, A. Habib, 2010, Current neurology and neuroscience reports.

Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.

D. Ganger, E. Wang, M. Mulcahy, 2014, Journal of vascular and interventional radiology : JVIR.